After the success of 2009's conference, SMi is proud to present their 6th Annual Imaging in Oncology. Taking place in London, UK, this conference will focus on a wide range of imaging techniques in a wide range of settings - from the preclinical, to the clinical, to the future of oncological imaging.  You will hear presentations from the leading experts in their fields on the latest developments in MRI, PET, SPECT, IR, Raman Sepctroscopy and more. The changes RECIST 1.1 has made - an assessment one year on.  How is MRI being used to guide biopsies?  Can less harmful techniques than PET be as effective in imaging a tumour?  Are nanoparticles the future for advanced cancer imaging?  Looking beyond tumour size - what techniques can help us understand the internal workings of a tumour?  How can we reduce the harmful effects of imaging?  How effective is proteomic profiling using mass spectrometry in diagnostics? Attend this event to discover the power of imaging for developing new drugs, following the reaction to therapies and developing a personalised approach to the treatment of cancer. Fancy speaking at the conference?  Do you know of anyone who may be interested in speaking?  We are always on the look-out for new speakers for our upcoming conferences.  Let us know: smiproduction@smi-online.co.uk. For sponsorship and exhibitioning opportunites, contact  sponsorshipdept@smi-online.co.uk.

Why should you attend this event?

Delegates at this conference will learn about: Guidelines for imaging in clinical trials - one year on from RECIST 1.1 - where to go now? New techniques being developed for MRI, PET, SPECT, SORS, Flow Cytometry and Mass Spectrometry Clinical imaging with a focus on breast cancer Preclinical imaging with a view to developing personalised cancer therapies Future developments and improving the safety of imaging technologies

How you will benefit from attending this conference: Hear from the leading lights of the imaging world about their latest research into imaging technique See imaging techniques you know being used for procedures you do not know Learn where the future lies for imaging in oncology Network with the people you need to know in the imaging arena

Feedback from SMi's Imaging in Oncology 2009:

"Good mix of clinical and preclinical presentations" - Senior Representative, Cancer Research UK

"Very good on imaging in drug development" - Senior Representative, Imperial College London

Hear keynote addresses from:

Robert Morgan, Senior Vice President, Regulatory Affairs, Quality and Clinical Development, Ziopharm Oncology

Daniel Bradley, Scientist II, Millennium

Philip Murphy, Director of Imaging, Oncology Medicines Development Centre, GlaxoSmithKline

Ridwaan Jhetam, Global Clinical Operations Head of Oncology, Johnson & Johnson

Our expert speaker line-up also includes:

Werner Scheuer, Group Leader, Preclinical Optical Imaging, Pharmacology TR-PD, Pharmaceutical Research, Roche Diagnostics

Jean-Frederic Salazar, Principal Scientist, Lead Pre-Clinical Oncology, GlaxoSmithKline

Gabriela Grigorean, Co-Ordinator, Mass Spectrometry Unity, European Institute of Oncology

Peter King, Senior Scientist, Oncology Discovery Research, Johnson & Johnson

Jocelyne Flament, Head, Medical Department, EORTC

Nick Stone, Head of Biophotonics Research Unity, Gloucestershire Hospitals NHS Foundation Trust

Kevin Brindle, Professor of Biomedical Magnetic Resonance, Cambridge University

Brandon Whitcher, Director, MRI Modelling, GlaxoSmithKline

Nich Hughes, Postdoctoral Fellow, University of Oxford and Stanfod University

Gordon McVie, Senior Consultant, Scientific Directorate, European Institute of Oncology

Lindsay Turnbull, Professor of Radiology & Scientific Director, Centre for MR Investigations, University of Hull

Omer Casher, Manager, Medical Imaging IT, GSK Clinical Imaging Centre

Karoline Meurer, Managing Director, RadPharm

Daniela Bokor, Medical Director Ultrasound, Group Research and Development, Bracco Imaging

Who should attend?

Chief Executives, Vice Presidents, Directors, Heads, Managers, Chief Scientists and Group Leaders of Oncology Oncological Imaging Medical Imaging Regulatory Affairs Research and Development Clinical Technology Cancer Drug Development Clinical Studies Discovery Medicine Specialised Therapeutics Oncology Consultancy Legislation & Policy Advice Safety Assessment Informatics Experimental Medicine

Attendees at our previous Imaging in Oncology Conferences came from

Previous delegates worked for

Amgen    AstraZeneca    Bayer    Bioscan Europe    Boehringer Ingelheim    Bristol-Myers Squibb    Cancer Research UK    Eisai    Eli Lilly    F.Hoffmann-La Roche    GE Healthcare    GlaxoSmithKline    Merck    Millennium Pharmaceuticals    Novartis    Pfizer    Sanofi-Aventis    Schering Plough    Wyeth

Venue details

Crowne Plaza St James Hotel 45-51 Buckingham Gate London SW1E 6AF    Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 6307 www.london.crowneplaza.com

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs. In the heart of Westminster, it is just a stone's throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.  

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food andBank Westminster with a modern British menu.

A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.

Booking: Book your accommodation at SMi discounted rates by: Calling us on +44 (0)870 9090 713 Sending a fax to +44 (0)870 9090 714 Emailing hotels@smi-online.co.uk   SMi discounted rates include Continental Breakfast & VAT £ 205.63 / Standard room / night for single occupancy £ 229.13 Executive  room / night for single occupancy